These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 35939178)
1. Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis. Prinz J; Maffulli N; Fuest M; Walter P; Hildebrand F; Migliorini F Int J Clin Pharm; 2022 Oct; 44(5):1087-1101. PubMed ID: 35939178 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Topical Administration of Corticosteroids for the Management of Dry Eye Disease: Systematic Review and Meta-Analysis. Prinz J; Maffulli N; Fuest M; Walter P; Bell A; Migliorini F Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36431067 [TBL] [Abstract][Full Text] [Related]
3. Honey-Related Treatment Strategies in Dry Eye Disease. Prinz J; Maffulli N; Fuest M; Walter P; Hildebrand F; Migliorini F Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242545 [TBL] [Abstract][Full Text] [Related]
4. Acupuncture for the management of dry eye disease. Prinz J; Maffulli N; Fuest M; Walter P; Hildebrand F; Migliorini F Front Med; 2022 Dec; 16(6):975-983. PubMed ID: 36152126 [TBL] [Abstract][Full Text] [Related]
5. Chloroquine and Hydroxychloroquine in the Treatment of Dry Eye Disease. Prinz J; Maffulli N; Fuest M; Walter P; Hildebrand F; Migliorini F Diseases; 2023 Jun; 11(2):. PubMed ID: 37366873 [TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay. Messmer EM; von Lindenfels V; Garbe A; Kampik A Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial. Eom Y; Chung SH; Chung TY; Kim JY; Choi CY; Yoon KC; Ko BY; Kim HK; Kim MK; Lee HK; Song JS; Hyon JY; Seo KY; Lee JS; Kim HM BMC Ophthalmol; 2023 Aug; 23(1):343. PubMed ID: 37537533 [TBL] [Abstract][Full Text] [Related]
8. Corneal permeability changes in dry eye disease: an observational study. Fujitani K; Gadaria N; Lee KI; Barry B; Asbell P BMC Ophthalmol; 2016 May; 16(1):53. PubMed ID: 27177442 [TBL] [Abstract][Full Text] [Related]
9. Dry eye disease among Glaucoma patients on topical hypotensive medications, in a tertiary hospital, Ethiopia. Sahlu M; Giorgis AT BMC Ophthalmol; 2021 Mar; 21(1):155. PubMed ID: 33785013 [TBL] [Abstract][Full Text] [Related]
10. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease. Downie LE; Ng SM; Lindsley KB; Akpek EK Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055 [TBL] [Abstract][Full Text] [Related]
11. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines. Choi MG; Yeo JH; Kang JW; Chun YS; Lee JK; Kim JC Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease. Lee HS; Ji YS; Yoon KC Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of incomplete blinking as a measurement of dry eye disease. Jie Y; Sella R; Feng J; Gomez ML; Afshari NA Ocul Surf; 2019 Jul; 17(3):440-446. PubMed ID: 31152804 [TBL] [Abstract][Full Text] [Related]
14. Autologous Serum Eye Drops versus Artificial Tear Drops for Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Wang L; Cao K; Wei Z; Baudouin C; Labbé A; Liang Q Ophthalmic Res; 2020; 63(5):443-451. PubMed ID: 31884498 [TBL] [Abstract][Full Text] [Related]
15. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain. Ozen S; Ozer MA; Akdemir MO Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time. Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481 [TBL] [Abstract][Full Text] [Related]
17. Oral vitamin D Lin Y; Su H; Wu J; Yuan M; Zhang Y Int Ophthalmol; 2022 Oct; 42(10):3145-3152. PubMed ID: 35551580 [TBL] [Abstract][Full Text] [Related]
18. Alteration of corneal biomechanical properties in patients with dry eye disease. Satitpitakul V; Taweekitikul P; Puangsricharern V; Kasetsuwan N; Reinprayoon U; Kittipibul T PLoS One; 2021; 16(7):e0254442. PubMed ID: 34252118 [TBL] [Abstract][Full Text] [Related]
19. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study. Yu K; Bunya V; Maguire M; Asbell P; Ying GS; Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415 [TBL] [Abstract][Full Text] [Related]
20. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye. Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]